Shearman & Sterling advised Vitruvian Partners on its acquisition of CRF Health from Verdane funds for an undisclosed sum.
CRF Health is the leading provider of electronic Clinical Outcome Assesments (eCOA) solutions for the life sciences industry with experience in about 550 trials, over 100 languages and across 74 countries.
Vitruvian is an independent private equity firm that specializes in middle-market buyouts, growth buyouts and growth capital investments in the UK and elsewhere in Northern Europe. Vitruvian’s expertise as principals in the industry dates back to 1990.
The Shearman & Sterling team advising on the transaction included lawyers in the firm’s London, New York, Washington, DC and Menlo Park Offices. The team was led by partner Simon Burrows (London-M&A) with support from partners Richard Hsu (Menlo Park- M&A), Peter Hayes (London-Finance), John Cannon (New York-Real Estate), Thomas Donegan (London-FIA&FR), Matthew Readings (London-Antitrust) and John Adams (London-Asset Management) and counsel Eileen O'Pray (Menlo Park-Tax), Lucy Keeble (London-Real Estate), Sam Whitaker (London-Compensation, Governance & ERISA) and Simon Letherman (London-Tax). Associates Joseph Bradley, Anna Cooklin, Tessa Parkes, Roísín McCourt, Paul Pasalic (all London-M&A), George Milton, Sebastian Krujatz (both London-Antitrust), Gerald Feige (Washington, DC-Tax), Nina Garnham, Amy Watt (both London-Asset Management), Shane Burke (London-Finance), Oliver Lynch (London – FIA&FR), Gabriel Ng (London-Tax), Benjamin Petersen (Menlo Park-IP), Rebecca Lee (London-Real Estate) and Kelly Hamren-Anderson (New York - Compensation, Governance & ERISA) supported on the transaction.
Recently, Shearman & Sterling advised Vitruvian on the acquisition of JacTravel (July 2014).